Related Experiment Video
Updated: Jun 28, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK)
Su-Ryang Kim1, Yoshiro Saito, Keiko Maekawa
1Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan. kim@nihs.go.jp
Abstract:
Deoxycytidine kinase (dCK) is a rate-limiting enzyme in the activation of nucleoside anticancer drugs, such as gemcitabine and cytarabine (Ara-C), to their active metabolites. In this study, the 5'-flanking region, 7 exons and their flanking introns of DCK were comprehensively screened for genetic variations in 256 Japanese cancer patients administered gemcitabine. Twenty-nine genetic variations, including twenty novel ones, were found: 11 in the 5'-flanking region, 1 in the 5'-untranslated region (UTR), 1 in the coding exon, 9 in the 3'-UTR, and 7 in the introns. The novel variations included -1110C>T, -757G>A, -639C>T, -465G>A, -402T>C, -224C>A, -199C>G, IVS1+38G>T, IVS2+78_+83delTTTTTC, IVS3-9C>T, IVS4+12T>C, IVS5+39T>C, 1357A>G, 1545A>T, 1572delA, 1736G>A, 1749G>A, 1838T>C, 1889G>A, and 2048A>T. The frequencies were 0.01 for IVS2+78_ +83delTTTTTC, 0.008 for -402T>C, 0.006 for -639C>T and IVS4+12T>C, 0.004 for -757G>A and 1572delA, and 0.002 for the other 14 variations. A known nonsynonymous SNP 364C>T (Pro122Ser) was detected at a 0.061 frequency. Using the detected polymorphisms, linkage disequilibrium analysis was performed, and 24 haplotypes were identified or inferred. Our findings suggest considerable ethnic differences in genetic variations of DCK and provide fundamental and useful information for genotyping DCK in the Japanese and probably other Asian populations.
Insights
This study identified 29 genetic variations in the deoxycytidine kinase (dCK) gene among Japanese cancer patients, including 20 novel variants. These findings highlight ethnic differences in dCK genetic makeup, crucial for cancer drug metabolism.
Area of Science:
- Pharmacogenomics
- Molecular Biology
- Oncology
Background:
- Deoxycytidine kinase (dCK) is essential for activating nucleoside anticancer drugs like gemcitabine.
- Genetic variations in dCK can influence drug efficacy and patient response.
- Understanding dCK genetic diversity is vital for personalized cancer therapy.
Purpose of the Study:
- To comprehensively screen the deoxycytidine kinase (DCK) gene for genetic variations in Japanese cancer patients.
- To identify novel genetic variations and analyze their frequencies.
- To provide foundational data for DCK genotyping in Asian populations.
Main Methods:
- Screening of the 5'-flanking region, 7 exons, and flanking introns of the DCK gene.
- Genetic analysis of 256 Japanese cancer patients treated with gemcitabine.
- Linkage disequilibrium analysis to identify haplotypes.
Main Results:
- Twenty-nine genetic variations were identified in DCK, with twenty being novel.
- Variations were found in the 5'-flanking region, UTRs, coding exon, and introns.
- A known nonsynonymous SNP (364C>T) was detected at a frequency of 0.061, and 24 haplotypes were identified or inferred.
Conclusions:
- Significant ethnic differences exist in DCK genetic variations.
- The identified variations and haplotypes provide essential information for DCK genotyping in Japanese and potentially other Asian populations.
- This research contributes to understanding the genetic basis of gemcitabine metabolism and response.
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Principles of Pharmacogenetics: Types of Genetic Variants
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Variation
Genes exist in different versions called alleles, which...

